| pioglitazone / Generic mfg. |
NCT00314561: The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome |
|
|
| Completed | 4 | 40 | RoW | Pioglitazone, Rosiglitazone | Korea University Anam Hospital | Metabolic Syndrome | | 12/06 | | |
NCT00926341: The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome |
|
|
| Completed | 4 | 110 | RoW | Pioglitazone, Telmisartan | Aligarh Muslim University | Metabolic Syndrome | 06/08 | 09/08 | | |
NCT00579813: Mechanisms Underlying Metabolic Syndrome in Obesity |
|
|
| Completed | 4 | 70 | US | Pioglitazone, Actos | Philip Kern, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Metabolic Syndrome, Insulin Resistance, Prediabetes | 01/09 | 01/11 | | |
NCT00835120: Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance |
|
|
| Completed | 4 | 34 | US | Pioglitazone, Actos | University Hospitals Cleveland Medical Center, National Alliance for Research on Schizophrenia and Depression, Takeda Pharmaceuticals North America, Inc. | Metabolic Syndrome, Bipolar Depression, Insulin Resistance | 04/13 | 04/13 | | |
